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RELIABLE 
CRYOPRESERVATION OF 
TRACHEA FOR ONE MONTH 
IN A NEW TREHALOSE 
SOLUTION 
We previously reported that trehalose, a reduced disaccharide, was effective 
in the preservation of lungs. In this study, we investigated the possibility of 
prolonged cryopreservation of tracheas in a preservative solution contain- 
ing trehalose. Five rings of cervical trachea were removed and immersed in 
the preservative solution. The harvested tracheas were then cryopreserved 
and stored in a deep freezer at -85  ° C. One month later, five rings of 
mediastinal trachea were removed. The cryopreserved cervical tracheas 
were thawed and autotransplanted in place of the excised mediastinal 
trachea (n = 6). The anastomotic site and graft were then covered with an 
omental pedicle. All six animals urvived for more than 6 months. All grafts 
survived without any evidence of atrophy or stenosis. Microscopic exami- 
nation of the grafts showed that the integrity of the tracheal tissues was 
maintained. Our findings show that consistent cryopreservation of the 
trachea for 1 month is possible in a preservative solution containing 
trehalose. (J THORAC CARDIOVASC SURG 1995;110:382-5) 
H. Yokomise, MD, K. Inui, MD, H. Wada, MD, S. Hasegawa, MD, 
N. Ohno, MD, and S. Hitomi, MD, Kyoto, Japan 
T he problem of the shortage of organ donors must be solved before tracheal transplantation be- 
comes applicable in the clinical setting. Experimen- 
tally, preservation of the trachea has been reported 
to be possible for about 20 hours by simple immer- 
sion in Euro-Collins (EC) solution. 1 The trachea 
consists of connective tissue, cartilage, and epithe- 
lium. Because the structure of the trachea is rela- 
tively simple, the possibility of prolonged cryo- 
preservation has been suggested. 2 Cryopreservation 
of cardiac valves 3 and cartilage < s has already been 
successful clinically. The shortage of donors can be 
resolved if prolonged cryopreservation f the tra- 
chea becomes possible. 
Trehalose is a nonreducing disaccharide that pro- 
tects the cellular membrane during cryopreserva- 
tion. 6-1° We previously reported the effectiveness of
trehalose in the preservation of lungs, n Others have 
reported that the combination of membrane-pene- 
trating cryoprotective agents (glycerol, dimethyl sul- 
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foxide [DMSO]) and nonpenetrating cryoprotective 
agents (trehalose) has a synergistic effect on cryo- 
preserved embryos and spermatozoa?' 10 
In this study, we were able to demonstrate the 
biologic feasibility of prolonged cryopreservation f 
the trachea with use of a preservation solution 
containing trehalose and DMSO. 
Material and methods 
Animals and anesthesia. Six adult mongrel dogs were 
used in the experiments. Anesthesia was induced by the 
intramuscular injection of ketamine (10 mg/kg) and the 
intravenous injection of sodium thiopental (15 mg/kg). 
After oral endotracheal intubation, the lungs were venti- 
lated mechanically with a Harvard pump (Harvard Appa- 
ratus Co., Inc., S. Natick, Mass.) at a tidal volume of 20 
ml/kg and a frequency of 20 breaths/rain. Anesthesia was 
maintained with 50% oxygen, 50% nitrogen monoxide, 
and 1% halothane. 
Harvest of grafts. Five rings of the cervical trachea 
were removed, and the tracheas were anastomosed nd to 
end. The excised section of trachea was simply immersed 
in a preservative solution that contained Dulbecco's mod- 
ified Eagle medium, 10% DMSO, 20% fetal calf serum, 
and 0.1 mol/L trehalose. The grafts were cryopreserved 
and stored in a deep freezer at -85 ° C. 
Autotransplantation of trachea. After 1 month, the 
cryopreserved trachea was thawed and autotransplanted 
to the mediastinal trachea. The graft was thawed at 37 ° C 
in an incubator and rinsed with physiologic saline solution 
10 times. Tracheal transplantation was done by the tech- 
nique described previously. 1 Briefly, five rings of medias- 
tinal trachea were removed after the preparation of an 
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Table I. ResMts of  the present study 
Status of grafts Pathologic f ndings 
Animal Survival of gratis (epithelium, 
no. (days) Shrinkage Malacia cartilage) 
c-1 200, killed Negative Negative Both preserved 
c-2 303, alive Negative Negative 
c-3 296, alive Negative Negative 
c-4 296, alive Negative Negative 
c-5 184, killed Negative Negative Both preserved 
c-6 185, killed Negative Negative Both preserved 
omental pedicle graft and a thawed tracheal autograft was
attached with 4-0 Prolene polypropylene continuous su- 
tures (Ethicon Inc., Somerville, N.J.). The anastomotic 
site and graft were covered with the omental pedicle graft. 
Intramuscular dministration of cefazolin (1 gin) was 
continued aily for 1 week after transplantation. 
Follow-up bronchoscopie and histologic examination. 
The graft was examined by bronchoscopy 1, 2, 3, and 4 
weeks after operation. Thereafter, bronchoscopic exami- 
nation was conducted every month. Tracheal tissue was 
examined histologically when the experimental nimals 
either died or were killed. 
The experimental dogs were treated with humane care 
according to t]~e guidelines outlined in the "Guide for the 
Care and Use of Laboratory Animals" prepared by the
Institute of Laboratory Animal Resources and published 
by the National Institutes of Health (NIH Publication No. 
86-23). 
Results 
Surviving animals (Table I). All animals (n = 6) 
survived for more than 6 months. Three of the 
animals were killed on postoperative day 184, 185, 
and 200, respectively, for histologic evaluation. The 
remaining three animals are still alive 296, 296, and 
303 days after transplantation. 
Macroscopic and gross findings. The grafts were 
edematous 1 week after operation. Both the mem- 
branous and cartilagenous portions appeared nor- 
mal and graft edema had vanished completely by 
1 month after operation. Endoscopic examination 
done 6 months after operation revealed no stenosis 
either in the anastomosis or in the grafts themselves; 
none of the grafts was atrophic (Fig. 1 and Fig. 2, A 
and B). 
Histologic evaluation. Normal epithelium cov- 
ered the graft surfaces, and the viability of the 
tracheal cartilages was maintained (Fig. 2, C). 
Discussion 
Many problems with regard to the clinical appli- 
cation of tracheal transplantation remain unsolved: 
immunosuppression,1, 12 blood supply to the grafts, 
extent of graft resection, 13and techniques of graft 
Fig. 1. Bronchoscopic findings 6 months after transplan- 
tation. There is no stenosis at the anastomotic site or in 
the graft. There is no evidence of atrophy in the graft. The 
graft is covered with normal epithelium. 
preservation. In this study, we evaluated a method 
of graft preservation. 
It is difficult o prepare quickly a graft that is both 
fresh and appropriate for the patient every time a 
transplantation is required. We have already re- 
ported that tracheas can be preserved for 20 hours 
by simple immersion in EC solution. 1 It is highly 
likely that preservation of tracheas is possible for a 
few days with this technique, but it remains un- 
known whether preservation over a few months is 
possible with simple immersion in EC solution. 
The trachea is an organ with a simple structure. It
consists of tracheal cartilage, mucus membrane, and 
connective tissues. For this reason, prolonged cryo- 
preservation of the trachea has been suggested 
previously. 2 Deschamps and colleagues 2 were suc- 
cessful in preserving tracheas for i week with mainly 
DMSO, a conventional cryoprotectant. However, 
their experimental findings are not sufficient to 
prove that their method is applicable for clinical 
transplantation, because their experiments consisted 
only of heterotopic grafts to the muscular pocket, 
which are not real transplantations. Moreover, the 
duration of successful preservation was relatively 
short in their cases (1 week). 
We performed orthotopic autotransplantations 
after 1 month of cryopreservation. The grafts sur- 
vived in all six animals in which the tracheal grafts 
were transplanted. Stenosis and dehiscence of the 
anastomotic site, graft necrosis, and atrophy were 
not observed. We believe that our technique of 
tracheal preservation is a near-perfect system. Our 
procedure, in which the tracheal grafts are stored 
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Fig. 2. A and B, Both endoscopy and gross examination show that grafts have taken well. No stenosis is 
seen at the anastomotic site, and there are no signs of necrosis or atrophy of the grafts. C, Histologic 
findings: normal epithelium covers the surface of the graft, and viability of the tracheal cartilage is 
maintained (original magnification × 100). 
directly in a deep freezer at -85 ° C without he use 
of a program freezer, is simple to do and is feasible 
for application in the clinical setting. 
DMSO and glycerol are cryoprotective agents 
that are used conventionally. It has been suggested 
that these agents protect cells against freezing by 
intracellular dehydration. 9' 10, 14 Dehydration is in- 
duced by the replacment of intracellular water with 
a cryoprotectant, which penetrates the cell mem- 
brane. On the other hand, trehalose cannot pene- 
trate cell membranes. It may act to maintain the 
viability of the cell membrane by replacing water 
molecules that are bound to the membrane phos- 
pholipids.8, 9 There are reports that the concomitant 
use of these two types of cryoprotective agents has a 
synergistic effect. 9' 10 These observations led us to 
undertake the present study. The concentrations of 
trehalose, DMSO, and fetal calf serum used in our 
experiments were determined according to the reg- 
imens of organ-preserving agents that have been 
reported to be most effective. 15-17 With respect o a 
control group, there has been no standard method of 
tracheal cryopreservation to use in a control group. 
Therefore we did not have such a group in this study. 
Although the effectiveness of trehalose itself as a 
cryoprotective agent and its synergistic effect when 
used in conjunction with other solutions have not been 
darned, our findings how that the preservation solu- 
tion we used in our experiments is effective. 
We demonstrated previously that allotransplanta- 
tion of the trachea is possible without he adminis- 
tration of immunosuppressive agents if the graft is 
exposed to preoperative irradiation (100,000 cGy). 1 
If irradiated grafts can be preserved for a long time 
by freezing, then tracheal transplantation can be 
done readily when required from a permanent s ock 
of these grafts in transplantation centers across the 
country. We are presently conducting experiments 
involving the prolonged preservation of irradiated 
grafts as part of the second step of our investigation. 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 2 
Yokornise t al. 3 8 5 
REFERENCES 
1. Yokomise H, Inui K, Wada H, et al. High-dose 
irradiation prevents rejection of canine tracheal allo- 
grafts. J Tl~o~c CAe, DIOVASC SURG 1994;107:1391-7. 
2. Deschamps C, Trastek VF, Ferguson JL, et al. Cryo- 
preservation of canine trachea: functional and histo- 
logical changes. Ann Thorac Surg 1989;47:208-12. 
3. Kirklin JK, Smith D, Novick W, et al. Long-term 
function of cryopreserved aortic homografts: a ten- 
year study. J THORAC CARDIOVASC SURG 1993;106: 
154-66. 
4. De Boer HH, Koudstaal J. The fate of meniscus 
cartilage after transplantation f cryopreserved non- 
tissue-antigen-matched allograft: a case report. Clin 
Orthop 1991;266:145-51. 
5. Hartog JM, Slavin AB, Kline SN. Reconstruction f
the temporomandibular joint with cryopreserved car- 
tilage and freeze-dried dura: a preliminary report. J
Oral Maxillofac Surg 1990;48:919-25. 
6. Crowe JH, Crowe LM, Chapman D. Preservation of
membranes in anhydrobiotic organisms: the role of 
trehalose. Science 1984;223:701-3. 
7. Bhandal IS, Hauptmann RM, Widholm JM. Treha- 
lose as cryoprotectant for the freeze preservation of
carrot and tobacco cells. Plant Physiol 1985;78:430-2. 
8. Rudolph AS, Crowe JH. Membrane stabilization dur- 
ing freezing: the role of two natural cryoprotectants, 
trehalose and proline. Cryobiology 1985;22:367-77. 
9. Honadel TE, Killian GJ. Cryopreservation f murine 
embryos with trehalose and glycerol. Cryobiology 
1988;25:331-7. 
10. Terada T, Ashizawa K, Maeda T, Tsutsumi Y. Effi- 
cacy of trehalose in cryopreservation of chicken sper- 
matozoa. Jpn J Anim Reprod 1989;35:20-5. 
11. Hirata T, Fukuse T, Liu C, et al. Effects of trehalose 
in canine lung preservation. Surgery 1994;115: 
102-7. 
12. Moriyama S, Shimizu N, Teramoto S. Experimental 
tracheal allotransplanation using omentopexy. Trans- 
plant Proc 1989;21:2596-600. 
13. Nakanishi R, Shirakusa T, Mitsudomi T. Maximum 
length of tracheal autografts in dogs. J THORAC CAR- 
DIOVASC SURG 1993;106:1081-7. 
14. Meryman HT, Williams RJ, Douglas MSJ. Freezing 
injury from "solution effects" and its prevention by 
natural or artificial cryoprotection. Cryobiology 1977; 
14:287-302. 
15. Brockbank KGM, Carpenter JF, Dawson PE. Effects 
of storage temperature on viable bioprosthetic heart 
valves. Cryobiology 1992;29:537-42. 
16. Bujia J, Pitzke P, Wilmes E, Hammer C. Culture and 
cryopreservation f chondrocytes from human carti- 
lage: relevance for cartilage allografting in otolaryn- 
gology. J Otorhinolaryngol Relat Spec 1992;54:80-4. 
17. Kawabe N, Yoshinao M. Cryopreservation f carti- 
lage. Int Orthop 1990;14:231-5. 
